NCT04104373

The Ontario Neurodegenerative Disease Research Initiative

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 522 (actual)
• Sponsor: Ontario Neurodegeneration Disease Research Initiative · Academic / Other
• Sex: All
• Age: 55 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The Ontario Neurodegenerative Disease Research Initiative (ONDRI) is a province-wide collaboration studying dementia and how to improve the diagnosis and treatment of neurodegenerative diseases including: * Alzheimer's disease (AD) * Parkinson's disease (PD) * amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) * frontotemporal lobar degeneration (FTD) * vascular cognitive impairment, resulting from stroke (VCI)

Detailed description

The Ontario Neurodegenerative Disease Research Initiative (ONDRI) is a research program designed to investigate similarities and differences of dementia among five diseases that will improve the diagnosis and treatment of neurodegeneration. The focus is on diseases that are associated with dementia: Alzheimer's disease/mild cognitive impairment, Parkinson's disease, amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), frontotemporal lobar degeneration, and vascular cognitive impairment (resulting from stroke). ONDRI is a province-wide collaboration between more than 50 of Ontario's world-class neurodegenerative disease researchers and clinicians, four patient advocacy groups, the industrial sector, and more than 20 clinical, academic and research centres carried out in partnership with the Ontario Brain Institute (OBI). Instead of only studying what's unique, our long-term observational study is seeking out the common early indicators and risk factors of the five diseases. Our mandate is to ensure that the findings from the data collected are transformed into new diagnostic methods that will help detect diseases earlier, improved clinical practice that puts patients first, and eventually new effective treatments that will slow the diseases from progressing or even prevent the disease so people can continue to enjoy the later years of their lives. More than 600 participants will be followed for up to three years and will complete assessments for genomics, gait and balance, eye measurements, neuropsychology, and neuroimaging and will donate their data to a comprehensive integrated data management system called Brain-CODE.

Conditions

• Alzheimer Disease
• Amyotrophic Lateral Sclerosis
• Frontotemporal Dementia
• Parkinson Disease
• Stroke

Interventions

Type	Name	Description
OTHER	Observational Cohort

Timeline

• Start date: 2014-07-07
• Primary completion: 2018-03-31
• Completion: 2018-04-30
• First posted: 2019-09-26
• Last updated: 2024-04-02

Locations

12 sites across 1 country: Canada